Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
8.02
-0.19 (-2.31%)
At close: Aug 13, 2025, 4:00 PM
8.20
+0.18 (2.24%)
Pre-market: Aug 14, 2025, 9:03 AM EDT
Verastem Market Cap
Verastem has a market cap or net worth of $493.59 million as of August 14, 2025. Its market cap has increased by 611.23% in one year.
Market Cap
493.59M
Enterprise Value
413.99M
1-Year Change
611.23%
Ranking
Category
Stock Price
$8.02
Market Cap Chart
Since January 27, 2012, Verastem's market cap has increased from $213.30M to $493.59M, an increase of 131.41%. That is a compound annual growth rate of 6.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 493.60M | 114.52% |
| Dec 31, 2024 | 230.10M | 11.86% |
| Dec 29, 2023 | 205.70M | 143.14% |
| Dec 30, 2022 | 84.60M | -77.35% |
| Dec 31, 2021 | 373.50M | 3.29% |
| Dec 31, 2020 | 361.60M | 263.05% |
| Dec 31, 2019 | 99.60M | -59.81% |
| Dec 31, 2018 | 247.80M | 99.36% |
| Dec 29, 2017 | 124.30M | 200.24% |
| Dec 30, 2016 | 41.40M | -39.74% |
| Dec 31, 2015 | 68.70M | -70.98% |
| Dec 31, 2014 | 236.70M | -19.05% |
| Dec 31, 2013 | 292.40M | 56.53% |
| Dec 31, 2012 | 186.80M | -12.42% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 571.28B |
| Johnson & Johnson | 419.32B |
| AbbVie | 349.43B |
| Abbott Laboratories | 229.77B |
| UnitedHealth Group | 229.42B |
| Novartis AG | 228.69B |
| AstraZeneca | 227.85B |
| Novo Nordisk | 222.88B |